FA01.06: ON THE RELATIONSHIP BETWEEN HISTOLOGY, ESOPHAGEAL-GASTRIC INTESTINAL METAPLASIA, GREATER CURVATURE LYMPHATIC METASTASES AND SURVIVAL IN SIEWERT II ADENOCARCINOMA. (14th September 2018)
- Record Type:
- Journal Article
- Title:
- FA01.06: ON THE RELATIONSHIP BETWEEN HISTOLOGY, ESOPHAGEAL-GASTRIC INTESTINAL METAPLASIA, GREATER CURVATURE LYMPHATIC METASTASES AND SURVIVAL IN SIEWERT II ADENOCARCINOMA. (14th September 2018)
- Main Title:
- FA01.06: ON THE RELATIONSHIP BETWEEN HISTOLOGY, ESOPHAGEAL-GASTRIC INTESTINAL METAPLASIA, GREATER CURVATURE LYMPHATIC METASTASES AND SURVIVAL IN SIEWERT II ADENOCARCINOMA
- Authors:
- Lugaresi, Marialuisa
Mattioli, Benedetta
Tassi, Valentina
Daddi, Niccolò
Ruffato, Alberto
Raulli, Gian
Malvi, Deborah
D'Errico, Antonietta
Mattioli, Sandro - Abstract:
- Abstract: Background: In Siewert type II adenocarcinoma we investigated the relationship between adenocarcinoma subtypes and survival, histologic/biologic patterns related to the presence/absence of gastric greater curvature metastases. Methods: 154 patients who underwent primary transthoracic esophageal resection, total gastrectomy, thoracic-abdominal lymphadenectomy according to a research prospective protocol were considered. Cases were categorized in intestinal and diffuse subtypes, in Barrett's-like, cardiopyloric-like, and gastric-like adenocarcinoma according to the presence/absence of intestinal metaplasia in esophagus and stomach. Cancer specific survival and gastric greater curvature metastases were studied in those categories. Results: Pathological stage (7 th TNM ed) was IA-IIA in 11%; IIB in 15.6%; IIIA-IV in 73.4%. Cases were: 59% intestinal-type, 41% diffuse-type; Barrett's-type 1.3%, cardiopyloric-type 65%, gastric-type 33.7%. Greater gastric curvature lymph node metastases were detected in 22%, in stage IIIa-IV only, intestinal type 47%; diffuse type 53%. The number of metastatic lymph nodes at station 4 was higher in cardiopyloric-like than in gastric-like type ( P < .0001).Five years cancer-specific survival of 154 cases was 40.5%, 59.4.% for intestinal type, 0% for diffuse type; 5-year cancer-specific survival in the absence/presence of greater gastric curvature metastases was respectively 48.7% and 14.9%, for intestinal type it was 67.4% and 27.9%.Abstract: Background: In Siewert type II adenocarcinoma we investigated the relationship between adenocarcinoma subtypes and survival, histologic/biologic patterns related to the presence/absence of gastric greater curvature metastases. Methods: 154 patients who underwent primary transthoracic esophageal resection, total gastrectomy, thoracic-abdominal lymphadenectomy according to a research prospective protocol were considered. Cases were categorized in intestinal and diffuse subtypes, in Barrett's-like, cardiopyloric-like, and gastric-like adenocarcinoma according to the presence/absence of intestinal metaplasia in esophagus and stomach. Cancer specific survival and gastric greater curvature metastases were studied in those categories. Results: Pathological stage (7 th TNM ed) was IA-IIA in 11%; IIB in 15.6%; IIIA-IV in 73.4%. Cases were: 59% intestinal-type, 41% diffuse-type; Barrett's-type 1.3%, cardiopyloric-type 65%, gastric-type 33.7%. Greater gastric curvature lymph node metastases were detected in 22%, in stage IIIa-IV only, intestinal type 47%; diffuse type 53%. The number of metastatic lymph nodes at station 4 was higher in cardiopyloric-like than in gastric-like type ( P < .0001).Five years cancer-specific survival of 154 cases was 40.5%, 59.4.% for intestinal type, 0% for diffuse type; 5-year cancer-specific survival in the absence/presence of greater gastric curvature metastases was respectively 48.7% and 14.9%, for intestinal type it was 67.4% and 27.9%. Histological subtype was an independent prognostic factor. Conclusion: The radical difference of 5 year survival between intestinal and diffuse types of Siewert type II adenocarcinoma after primary surgery, the relevant frequency and biologic patterns of station 4 nodal metastases do require further investigation in light of current indications for neoadjuvant therapy and total gastrectomy. Disclosure: All authors have declared no conflicts of interest. … (more)
- Is Part Of:
- Diseases of the esophagus. Volume 31(2018)Supplement 1
- Journal:
- Diseases of the esophagus
- Issue:
- Volume 31(2018)Supplement 1
- Issue Display:
- Volume 31, Issue 1 (2018)
- Year:
- 2018
- Volume:
- 31
- Issue:
- 1
- Issue Sort Value:
- 2018-0031-0001-0000
- Page Start:
- 2
- Page End:
- 3
- Publication Date:
- 2018-09-14
- Subjects:
- adenocarcinoma of the esophagus -- esophageal surgery -- Esophageal cancer
Esophagus -- Diseases -- Periodicals
616.32 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1442-2050 ↗
http://www.wiley.com/bw/journal.asp?ref=1120-8694 ↗
https://academic.oup.com/dote ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1093/dote/doy089.FA01.06 ↗
- Languages:
- English
- ISSNs:
- 1120-8694
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3598.210000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16722.xml